Comparative study of the vasorelaxant activity, superoxide-scavenging ability and cyclic nucleotide phosphodiesterase-inhibitory effects of hesperetin and hesperidin

Álvarez E, Orallo F (2001) Preliminary study of the potential vasodilator effects on rat aorta of hesperidin and hesperetin, two flavonoids from citrus fruit [abstract 9P076]. Fundam Clin Pharmacol 15:125

Álvarez E, Leiro J, Orallo F (2002) Effect of (?)-epigallocatechin 3-gallate on respiratory burst of rat macrophages. Int Immunopharmacol 2:849?855

Beretz A, Anton R, Stoclet JC (1978) Flavonoid compounds are potent inhibitors of cyclic AMP phosphodiesterase. Experientia 34:1054?1055

Calderone V, Chericoni S, Martinelli C, Testai L, Nardi A, Morelli I, Breschi MC, Martinotti E (2004) Vasorelaxing effects of flavonoids: investigation on the possible involvement of potassium channels. Naunyn-Schmiedebergs Arch Pharmacol (online publication at http://dx.doi.org/10.1007/s00210-004-0964-z)

Eckly-Michel AE, Martin V, Lugnier C (1997) Involvement of cyclic nucleotide-dependent protein kinases in cyclic AMP-mediated vasorelaxation. Br J Pharmacol 122:158?164

Edwards G, Weston AH (1995) Pharmacology of the potassium channel openers. Cardiovasc Drugs Ther 9:185?193

Emam AM, Elias R, Moussa AM, Faure R, Debrauwer L, Balansard G (1998) Two flavonoid triglycosides from Buddleja madagascariensis. Phytochemistry 48:739?742

Feng MG, Feng GH, Zhou QG (1998) Effects of methylhesperidin on coronary, renal and cerebral circulation in dogs. Chung Kuo Yao Li Hsueh Pao 9:548?550

Galati EM, Trovato A, Kirjavainen S, Forestieri AM, Rossitto A, Monforte MT (1996) Biological effects of hesperidin, a Citrus flavonoid (Note III): antihypertensive and diuretic activity in rat. Farmaco 51:219?221

Garg A, Garg S, Zaneveld LJ, Singla AK (2001) Chemistry and pharmacology of the Citrus bioflavonoid hesperidin. Phytother Res 15:655?669

Ibarra M, Perez-Vizcaíno F, Cogolludo A, Duarte J, Zaragoza-Arnáez F, López-López JG, Tamargo J (2002) Cardiovascular effects of isorhamnetin and quercetin in isolated rat and porcine vascular smooth muscle and isolated rat atria. Planta Med 68:307?310

Kameni Tcheudji JF, Lebeau L, Virmaux N, Maftei CG, Cote RH, Lugnier C, Schultz P (2001) Molecular organisation of bovine rod cGMP-phosphodiesterase 6. J Mol Biol 310:781?791

Karaki H, Ozaki H, Hori M, Mitsui-Saito M, Amano KI, Harada KI, Miyamoto S, Nakazawa H, Won KJ, Sato K (1997) Calcium movements, distribution, and functions in smooth muscle. Pharmacol Rev 49:157?230

Keravis TM, Wells JN, Hardman JG (1980) Cyclic nucleotide phosphodiesterase activities from pig coronary arteries. Lack of interconvertibility of major forms. Biochim Biophys Acta 613:116?129

Knapp J, Boknik P, Linck B, Luss H, Muller FU, Petertonjes L, Schmitz W, Neumann J (2000) Cantharidin enhances norepinephrine-induced vasoconstriction in an endothelium-dependent fashion. J Pharmacol Exp Ther 294:620?626

Komas N, Lugnier C, Stoclet JC (1991) Endothelium-dependent and independent relaxation of the rat aorta by cyclic nucleotide phosphodiesterase inhibitors. Br J Pharmacol 104:495?503

Liu H, Xiong Z, Sperelakis N (1997) Cyclic nucleotides regulate the activity of l-type calcium channels in smooth muscle cells from rat portal vein. J Mol Cell Cardiol 29:1411?1421

Lorenz JN, Bielefeld DR, Sperelakis N (1994) Regulation of calcium channel current in A7r5 vascular smooth muscle cells by cyclic nucleotides. Am J Physiol 266:C1656?C1663

Lugnier C, Komas N (1993) Modulation of vascular cyclic nucleotide phosphodiesterases by cyclic GMP: role in vasodilatation. Eur Heart J 14:141?148

Lugnier C, Schini V (1990) Characterization of cyclic nucleotide phosphodiesterases in bovine aortic endothelial cells in culture. Biochem Pharmacol 39:75?84

Lugnier C, Schoeffter P, Le Bec A, Strouthou E, Stoclet JC (1986) Selective inhibition of cyclic nucleotide phosphodiesterases of human, bovine and rat aorta. Biochem Pharmacol 35:1743?1751

Maurice DH, Palmer D, Tilley DG, Dunkerley HA, Netherton SJ, Raymond DR, Elbatarny HS, Jimmo SL (2003) Cyclic nucleotide phosphodiesterase activity, expression, and targeting in cells of the cardiovascular system. Mol Pharmacol 64:533?546

Middleton E Jr, Kandaswami C, Theoharides TC (2000) The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, cancer. Pharmacol Rev 52:673?751

Nichols MR, Morimoto BH (2000) Differential inhibition of multiple cAMP phosphodiesterase isozymes by isoflavones and tyrphostins. Mol Pharmacol 57:738?745

Noguera MA, Ivorra MM, Lugnier C, D?Ocon P (2001) Role of cyclic nucleotide phosphodiesterase isoenzymes in contractile responses of denuded rat aorta related to various Ca2+ sources. Naunyn-Schmiedebergs Arch Pharmacol 363:612?619

Okamura N, Haraguchi H, Hashimoto K, Yagi A (1994) Flavonoids in Rosmarinus officinalis leaves. Phytochemistry 37:1463?1466

Orallo F (1996) Regulation of cytosolic calcium levels in vascular smooth muscle. Pharmacol Ther 69:153?171

Orallo F (1997) Study of the in vivo and in vitro cardiovascular effects of a hydralazine-like vasodilator agent (HPS-10) in normotensive rats. Br J Pharmacol 121:1627?1636

Orallo F, Álvarez E, Camiña M, Leiro JM, Gómez E, Fernández P (2002) The possible implication of trans-resveratrol in the cardioprotective effects of long-term moderate wine consumption. Mol Pharmacol 61:294?302

Quast U (1993) Do the K+ channel openers relax smooth muscle by opening K+ channels? Trends Pharmacol Sci 14:332?337

Rybalkin SD, Yan C, Bornfeldt KE, Beavo JA (2003) Cyclic GMP phosphodiesterases and regulation of smooth muscle function. Circ Res 93:280?291

Sakata K, Hirose Y, Qiao Z, Tanaka T, Mori H (2003) Inhibition of inducible isoforms of cyclooxygenase and nitric oxide synthase by flavonoid hesperidin in mouse macrophage cell line. Cancer Lett 199:139?145

Schoeffter P, Lugnier C, Demesy-Waeldele F, Stoclet JC (1987) Role of cyclic AMP- and cyclic-GMP-phosphodiesterases in the control of cyclic nucleotide levels and smooth muscle tone in rat isolated aorta: a study with selective inhibitors. Biochem Pharmacol 36:3965?3972

Spencer JP, Chowrimootoo G, Choudhury R, Debnam ES, Srai SK, Rice-Evans C (1999) The small intestine can both absorb and glucuronidate luminal flavonoids. FEBS Lett 458:224?230

Stoclet JC, Keravis T, Komas N, Lugnier C (1995) Cyclic nucleotide phosphodiesterases as therapeutic targets in cardiovascular diseases. Expert Opin Investig Drugs 4:1081?1100

Van der Zypp A, Rechtman M, Majewski H (2000) The role of cyclic nucleotides and calcium in the relaxation produced by amrinone in rat aorta. Gen Pharmacol 34:245?253

Vidrio H, Fernández G, Medina M, Álvarez E, Orallo F (2003) Effects of hydrazine derivatives on vascular smooth muscle contractility, blood pressure and cGMP production in rats: comparison with hydralazine. Vasc Pharmacol 40:13?21

Wakabayashi I, Sakamoto K, Hatake K (1995) Inhibitory effects of cadmium ion on extracellular Ca2+-independent contraction of rat aorta. Eur J Pharmacol 293:133?140